Phase 1 smallpox Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses.

MonkeypoxCowpoxPoxvirus Infection+1 more

China National Biotec Group Company Limited76 enrolled1 locationNCT07377175

Not Yet Recruiting

Phase 1

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Brincidofovir Administered Intravenously in Healthy Adult Subjects

smallpox

Chimerix, Inc.28 enrolled1 locationACTRN12617000928314

Recruiting

Phase 1

A Phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability and pharmacokinetics (PK) of escalating single dose of brincidofovir administered intravenously in healthy adult subjects

Adenovirussmallpox

Chimerix, Inc40 enrolled1 locationACTRN12616001657415